JAK1/2 inhibition increased the identification error rate and decreased the signal fidelity (increased noise) in all immune cell subtypes, resulting in a pattern of signaling dysregulation distinct from both controls and BC samples (Fig 5A). Here, JAK1 is linked to breast cancer.